title: A case of resistant spondyloarthritis (SpA) that responded to tacrolimus and mycophenolate treatment initiated at the time of renal transplantation for unrelated renal failure.
authors.affiliation: a Division of Rheumatology , McMaster University , Hamilton , ON , Canada.
authors.forename: M
authors.initials: M
authors.lastname: Larche
authors.affiliation: b Leeds Institute of Rheumatic and Musculoskeletal Medicine , University of Leeds , Leeds , UK.|c NIHR Leeds Musculoskeletal Biomedical Research Unit , Leeds Teaching Hospitals NHS Trust , Leeds , UK.
authors.forename: D
authors.initials: D
authors.lastname: McGonagle
mesh_terms: D000328:Adult; D001682:Biological Availability; D006084:Graft Rejection / Q000517:prevention & control*; D015796:HLA-B27 Antigen / Q000032:analysis; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000493:pharmacokinetics; D007676:Kidney Failure, Chronic / Q000150:complications / Q000601:surgery; D016030:Kidney Transplantation / Q000379:methods*; D008297:Male; D009173:Mycophenolic Acid / Q000008:administration & dosage / Q000493:pharmacokinetics; D025242:Spondylarthropathies / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology / Q000473:pathology; D016559:Tacrolimus / Q000008:administration & dosage / Q000493:pharmacokinetics; D016896:Treatment Outcome
chemical_list: D015796:HLA-B27 Antigen; D007166:Immunosuppressive Agents; D009173:Mycophenolic Acid; D016559:Tacrolimus